These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27435025)

  • 21. A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults.
    Block SL; Yi T; Sheldon E; Dubovsky F; Falloon J
    Vaccine; 2011 Nov; 29(50):9391-7. PubMed ID: 21983154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence update: GlaxoSmithKline's inactivated quadrivalent influenza vaccines.
    Bekkat-Berkani R; Ray R; Jain VK; Chandrasekaran V; Innis BL
    Expert Rev Vaccines; 2016; 15(2):201-14. PubMed ID: 26641539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular epidemiology and genetic characterization of influenza B virus in Lebanon during 2016-2018.
    AlIbrahim M; Assaf-Casals A; Massaad E; Shaker R; Soudani N; Fayad D; Chamseddine S; Lteif-Khoury M; Chmaisse A; Isaac I; Anan H; Sadaka C; Radwan N; Ghanem S; Naous A; Karam M; Andary R; Dbaibo G; Zaraket H
    Infect Genet Evol; 2019 Nov; 75():103969. PubMed ID: 31325610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usage of quadrivalent influenza vaccine among children in the United States, 2013-14.
    Rodgers L; Pabst LJ; Zhu L; Chaves SS
    Vaccine; 2015 Nov; 33(48):6517-8. PubMed ID: 26296494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recommendations for Prevention and Control of Influenza in Children, 2016-2017.
    COMMITTEE ON INFECTIOUS DISEASES
    Pediatrics; 2016 Oct; 138(4):. PubMed ID: 27600320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies.
    Verma S; Soto J; Vasudevan A; Schmeisser F; Alvarado-Facundo E; Wang W; Weiss CD; Weir JP
    PLoS One; 2017; 12(4):e0175733. PubMed ID: 28423025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic and antigenic typing of seasonal influenza virus breakthrough cases from a 2008-2009 vaccine efficacy trial.
    Durviaux S; Treanor J; Beran J; Duval X; Esen M; Feldman G; Frey SE; Launay O; Leroux-Roels G; McElhaney JE; Nowakowski A; Ruiz-Palacios GM; van Essen GA; Oostvogels L; Devaster JM; Walravens K
    Clin Vaccine Immunol; 2014 Mar; 21(3):271-9. PubMed ID: 24371255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quadrivalent inactivated influenza vaccine (VaxigripTetra™).
    Gresset-Bourgeois V; Leventhal PS; Pepin S; Hollingsworth R; Kazek-Duret MP; De Bruijn I; Samson SI
    Expert Rev Vaccines; 2018 Jan; 17(1):1-11. PubMed ID: 29157068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
    J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recommendations for prevention and control of influenza in children, 2013-2014.
    Committee on infectious diseases
    Pediatrics; 2013 Oct; 132(4):e1089-104. PubMed ID: 23999962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial.
    Hung IF; Zhang AJ; To KK; Chan JF; Li P; Wong TL; Zhang R; Chan TC; Chan BC; Wai HH; Chan LW; Fong HP; Hui RK; Kong KL; Leung AC; Ngan AH; Tsang LW; Yeung AP; Yiu GC; Yung W; Lau JY; Chen H; Chan KH; Yuen KY
    Lancet Infect Dis; 2016 Feb; 16(2):209-18. PubMed ID: 26559482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [DEVELOPMENT OF THE QUADRIVALENT LIVE ATTENUATED INFLUENZA VACCINE INCLUDING TWO INFLUENZA B LINEAGES--VICTORIA AND YAMAGATA].
    Desheva YA; Smolonogina TA; Doroshenko EM; Rudenko LG
    Vopr Virusol; 2016; 61(1):16-20. PubMed ID: 27145595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The 2001/2002 influenza season and the vaccine composition for the 2002/2003 season].
    Rimmelzwaan GF; de Jong JC; Bartelds AI; Wilbrink B; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1846-50. PubMed ID: 12382372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quadrivalent influenza vaccine (Sinovac Biotech) for seasonal influenza prophylaxis.
    Tao YY; Li JX; Hu YM; Hu YS; Zeng G; Zhu FC
    Expert Rev Vaccines; 2021 Jan; 20(1):1-11. PubMed ID: 33434084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comprehensive review of the epidemiology and disease burden of Influenza B in 9 European countries.
    Tafalla M; Buijssen M; Geets R; Vonk Noordegraaf-Schouten M
    Hum Vaccin Immunother; 2016 Apr; 12(4):993-1002. PubMed ID: 26890005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: a phase III, randomized trial.
    Tinoco JC; Pavia-Ruz N; Cruz-Valdez A; Aranza Doniz C; Chandrasekaran V; Dewé W; Liu A; Innis BL; Jain VK
    Vaccine; 2014 Mar; 32(13):1480-7. PubMed ID: 24486352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulation of influenza B lineages in northern Viet Nam, 2007-2014.
    Le TT; Pham TH; Pham TH; Nguyen le KH; Nguyen CT; Hoang VM; Tran TH; Nguyen VS; Ngo HG; Le QM
    Western Pac Surveill Response J; 2015; 6(4):17-23. PubMed ID: 26798557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The need for quadrivalent vaccine against seasonal influenza.
    Belshe RB
    Vaccine; 2010 Sep; 28 Suppl 4():D45-53. PubMed ID: 20713260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Introduction of a quadrivalent influenza vaccine in Italy: a budget impact analysis.
    Pitrelli A
    J Prev Med Hyg; 2016; 57(1):E34-40. PubMed ID: 27346938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control.
    Ray R; Dos Santos G; Buck PO; Claeys C; Matias G; Innis BL; Bekkat-Berkani R
    Hum Vaccin Immunother; 2017 Jul; 13(7):1640-1652. PubMed ID: 28532276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.